Trial Profile
A study investigating efficacy and safety of Suvorexant in combination with other sleep promoting medicines in patients with insomnia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2016
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Adverse reactions; Therapeutic Use
- 10 Oct 2016 New trial record